Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Monoclonal Gammopathy of Renal Significance
Guangzhou, Guangdong
Monoclonal Gammopathy of Renal Significance Clinical Trials in Guangzhou, Guangdong
1 recruiting
Guangzhou, Guangdong, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital
20 enrolled
3 locations
NCT06418477
Feedback